Insider Cluster (3 insiders) ·Filed Apr 20, 2026

BCAX

Bicara Therapeutics Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago
Insider cluster: 3 insiders, $0.7M total
Actionable Insight • Neutral

Insider sales are too small to signal negative conviction. The cluster appears to be routine portfolio diversification/tax planning. Focus on upcoming clinical catalysts (e.g., Phase 2 data) for near-term price action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
BCAX ▲ +26.97% at T+60d
NEUTRAL call ✓ call won +26.97% · α vs SPY +22.86% · entry $21.28 → $27.02
Entry anchored
Apr 28, 2026
via day open
T+1d
+1.41%
call +1.41% · α +0.39%
$21.58
settled 5mo ago
T+5d
+11.75%
call +11.75% · α +8.64%
$23.78
settled 5mo ago
T+20d
+2.21%
call +2.21% · α -3.84%
$21.75
settled 4mo ago
T+60d
+26.97%
call +26.97% · α +22.86%
$27.02
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Three top executives (CEO, CFO, CMO) sold a combined $692K in BCAX stock over the past week, but this represents only ~0.05% of the $1.5B market cap, making the cluster economically trivial and routine.

Key Financial Metrics

Direction
selling
Total Value
$692.0K
Insiders
3

Key Facts

  • CEO Claire Mazumdar sold 15K shares at ~$23.61 for $354K on Apr 20
  • CFO Ivan Hyep sold 9.2K shares at ~$23.00 for $212K on Apr 21
  • CMO David Raben sold 5.5K shares at ~$22.88 for $126K on Apr 27 (after exercising options)
  • Total open-market sales: ~$692K, or ~0.046% of BCAX's $1.5B market cap

Financial Impact

Insider selling totals ~$692K, negligible relative to market cap

insider holdingsfloat

Risk Factors

  • No material risk from this insider activity

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BCAX-1777420424259
20 reports for BCAX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BCAX — sortable, filterable
TypeNow
Aug 25, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$24.73 $19.78▼ −20.02%▼ −20.24%$18.25 (−26.18%)
Aug 14, 2026
7w ago
Press Release
NEUTRAL ★ 2/10
$24.28 $23.20▼ −4.45%▼ −2.46%$18.25 (−24.81%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 5/10
$23.63 $22.81▼ −3.47%▼ −1.72%$18.25 (−22.75%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$23.63 $22.81▼ −3.47%▼ −1.72%$18.25 (−22.75%)
Aug 11, 2026
7w ago
8-K
MIXED ★ 6/10
$23.76 $23.64▼ −0.51%▲ +0.55%$18.25 (−23.17%)
Aug 11, 2026
7w ago
Press Release
MIXED ★ 6/10
$23.76 $23.64▼ −0.51%▲ +0.55%$18.25 (−23.17%)
Jul 14, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$28.10 $23.76▼ −15.44%▼ −17.94%$18.25 (−35.04%)
Jun 11, 2026
16w ago
Institutional Cluster
BEARISH ★ 5/10
$21.28 $29.68▼ −39.47%▼ −37.58%$18.25 (+14.22%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$21.58 $26.34▲ +22.06%▲ +23.96%$18.25 (−15.41%)
May 11, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$22.92 $20.56▼ −10.30%▼ −9.99%$18.25 (−20.35%)
Showing 10 of 20

US Market Status

Market Open — Closes in 3h 57m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 28, 2026